Vertex is currently launching Casgevy for sickle cell disease (SCD). This is a 60/40 program partnered with CRISPR ...

The $5.3m seed funding will enable clock.bio to develop its atlas of rejuvenation factors and will also enable next steps in ...

In the world of neuroscience research, the mouse reigns supreme: in the US alone, tens of millions of mice are studied as a ...

In the debate over artificial general intelligence, it’s often the “doomers” ( Eliezer Yudkowsky) or showmen (OpenAI CEO Sam ...

Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach ...

CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...